vimarsana.com
Home
Live Updates
Post-Surgery Atezolizumab Fails to Provide Benefit in Combination With Chemotherapy for TNBC : comparemela.com
Post-Surgery Atezolizumab Fails to Provide Benefit in Combination With Chemotherapy for TNBC
Adjuvant atezolizumab did not provide a clinical benefit when added to chemotherapy in patients with triple-negative breast cancer.
Related Keywords
Italy ,
Milan ,
Lombardia ,
San Antonio ,
Texas ,
United States ,
Heather Mcarthur ,
Clinical Breast Cancer Research ,
Ut Southwestern Medical Center ,
European Breast Cancer Conference ,
Komen Distinguished Chair ,
Medical Center ,
Antonio Breast Cancer Symposium ,
Alexandra Impassion030 Trial ,
Nct03498716 ,
14th European Breast Cancer Conference ,
Atezolizumab ,
Atezolizumab Plus Chemotherapy ,
Triple Negative Breast Cancer ,
Ntnbc ,
comparemela.com © 2020. All Rights Reserved.